AgomAb Therapeutics N.V. American Shares

AGMB | NASDAQ

$7.49

-$0.46 (-5.79%)

At close: Oct 30, 2026, 4:00 PM ET

$7.49

$0.00 (0.00%)

After-hours: Oct 30, 2026, 7:30 PM ET

Fiscal Quarter Period Ending	Q4 2025 Dec 31, 2025	Q3 2025 Sep 30, 2025	Q4 2024 Dec 31, 2024
Revenue	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a
Operating Income	-16.53M	-15.36M	-11.81M
Interest Income	581K	173K	471K
Pretax Income	-17.4M	-18.28M	-11.73M
Net Income	-17.4M	-18.28M	-11.73M
Selling & General & Admin	3.25M	2.64M	1.38M
Research & Development	13.86M	12.99M	10.73M
Other Expenses	-589K	-274K	-298K
Operating Expenses	16.53M	15.36M	11.81M
Interest Expense	n/a	124K	n/a
Selling & Marketing Expenses	n/a	n/a	n/a
Cost & Expenses	16.53M	15.36M	11.81M
Income Tax Expense	n/a	n/a	4K
Shares Outstanding (Basic)	48.74M	42.49M	36.24M
Shares Outstanding (Diluted)	48.74M	42.49M	36.24M
EPS (Basic)	-0.36	-0.43	-0.32
EPS (Diluted)	-0.36	-0.43	-0.32
EBITDA	-17.62M	-18.05M	-11.8M
EBIT	-17.54M	-18.15M	-11.88M
Depreciation & Amortization	-83K	107K	85K